Basal insulin in the age of innovation: are diamonds still forever?
{{output}}
Introduction: Basal insulin has long served as a cornerstone in the management of type 2 diabetes. However, the emergence of glucose-lowering agents with cardiometabolic benefits - such as glucagon-like peptide 1 receptor agonist... ...
